NTRK3

protein-coding

neurotrophic receptor tyrosine kinase 3, the group of I-set domain containing|Receptor tyrosine kinases

Gene summary

This gene encodes a member of the neurotrophic tyrosine receptor kinase (NTRK) family. This kinase is a membrane-bound receptor that, upon neurotrophin binding, phosphorylates itself and members of the MAPK pathway. Signalling through this kinase leads to cell differentiation and may play a role in the development of proprioceptive neurons that sense body position. Mutations in this gene have been associated with medulloblastomas, secretory breast carcinomas and other cancers. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2011]

MANE transcript

NM_001012338.3

Inheritance

AD

ClinVar variants

U:68B:27

Top phenotype

NTRK3-related disorder

gnomAD constraint

pLI —, LoF o/e 0.12

Max pathogenic AF

—

Genomic locus

chr15:87,859,751-88,256,791

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~397.0 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

congenital heart diseaseNO_KNOWN

Inheritance Pattern: AD

Disease ID:MONDO:0005453

Submitter: ClinGen

*NTRK3* was first reported in relation to autosomal dominant congenital heart disease in 2014 (Werner et al. 2014, PMID:25196463). At least five unique missense variants in five individuals with congenital heart disease were reported in a publication (PMID: 25196463). Evidence disputing this gene-disease relationship includes case-level data. None of the five variants reported were scorable, as four were too frequent on gnomAD (MAF> 0.00001) to cause disease and one had an unaffected carrier mother. This gene-disease relationship is supported by expression data and two mouse models (PMIDs: 19187638, 9405689, 14550777). In summary, the evidence supporting the relationship between *NTRK3* and autosomal dominant congenital heart disease has been disputed and no valid evidence remains to support the claim. More evidence is needed to either support or entirely refute the role *NTRK3* plays in this disease. This classification was approved by the ClinGen Congenital Heart Disease GCEP on the meeting date February 6th, 2024 (SOP Version 10).

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to NTRK3 variants in ClinVar

10 Conditions Cataloged
not specifiedTotal: 58
not providedTotal: 23
NTRK3-related disorderTotal: 19
Entrectinib resistanceTotal: 2
Repotrectinib resistanceTotal: 1
Neonatal cardiomyopathyTotal: 1
Selitrectinib resistanceTotal: 1
Larotrectinib resistanceTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_001012338.3. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
17
clinvar
6
clinvar
24
missense
62
clinvar
3
clinvar
1
clinvar
66
nonsense
1
clinvar
1
start loss
0
frameshift
4
clinvar
4
splice donor/acceptor (+/-2bp)
0
Total006820795
Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 83 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_001012338.3RefSeqNP_001012338.118MANE Select
ENST00000629765.3EnsemblENSP00000485864.118MANE Select
NM_001007156.3RefSeqNP_001007157.114Standard
NM_001243101.2RefSeqNP_001230030.116Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Neurotrophin signaling pathway - Homo sapiens (human)
  • Central carbon metabolism in cancer - Homo sapiens (human)
  • Brain-Derived Neurotrophic Factor (BDNF) signaling pathway
  • Neuronal System
  • SHP2 signaling

Biological Process

  • activation of MAPK activity
  • neuron migration
  • negative regulation of protein phosphorylation
  • positive regulation of protein phosphorylation
  • transmembrane receptor protein tyrosine kinase signaling pathway

Molecular Function

  • p53 binding
  • transmembrane receptor protein tyrosine kinase activity
  • GPI-linked ephrin receptor activity
  • neurotrophin receptor activity
  • protein binding

Cellular Component

  • plasma membrane
  • integral component of plasma membrane
  • axon
  • receptor complex
  • glutamatergic synapse

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000360948
Coding exons
18
Length
381770
Individuals with no LoFs
125740
Homozygous LoFs
0
Heterozygous LoFs
8
Defined
125748
p
0.0000318
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense1.833754890.7670.00002935547
Missense (PolyPhen)94181.590.517652111
Synonymous-2.152291911.200.00001191622
Loss of Function5.18540.60.1230.00000202469

Population LoF Frequency

PopulationCAFp-valueStatus
African0.0000620.000062rare
Latino/Admixed American00.0absent
Ashkenazi Jewish00.0absent
East Asian00.0absent
Finnish00.0absent
European (Non-Finnish)0.0000440.000044rare
South Asian0.0000650.000065rare
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Receptor tyrosine kinase involved in nervous system and probably heart development. Upon binding of its ligand NTF3/neurotrophin-3, NTRK3 autophosphorylates and activates different signaling pathways, including the phosphatidylinositol 3-kinase/AKT and the MAPK pathways, that control cell survival and differentiation. {ECO:0000269|PubMed:25196463}.;
Disease
DISEASE: Note=Defects in NTRK3 are associated with susceptibility to congenital heart defects (CHD). A disease characterized by congenital developmental abnormalities involving structures of the heart. CHD are the most common major birth defects and the leading cause of death from congenital malformations. {ECO:0000269|PubMed:25196463}.;

Recessive Scores

pRec
0.527

Intolerance Scores

LoFtool
0.0394
RVIS EVS
-1.99
RVIS percentile EVS
1.76

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.963

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.